financetom
Business
financetom
/
Business
/
Canada's Pembina Pipeline to buy midstream assets from Veren
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canada's Pembina Pipeline to buy midstream assets from Veren
Sep 9, 2024 7:25 AM

Sept 9 (Reuters) - Canada's Pembina Pipeline ( PBA )

said on Monday it will buy some infrastructure assets in Alberta

Montney from oil producer Veren Inc ( VRN ) for about C$400

million ($294.9 million), to strengthen its midstream

operations.

WHY IT'S IMPORTANT

Consolidation in the pipeline and storage sector has been on

the rise since last year as North American production grows, and

as hurdles in getting new energy infrastructure approved and

built have made existing operators more valuable.

CONTEXT

Pembina Gas Infrastructure, which is jointly owned by KKR,

will acquire four oil battery sites in the Gold Creek and Karr

areas, which have a natural gas handling capacity of 320 million

cubic feet per day and liquids handling capacity of 53,000

barrels per day.

Veren ( VRN ), formerly known as Crescent Point Energy, would retain

operatorship of the Gold Creek and Karr sites and assume

operatorship of the existing Pembina-owned batteries in the

area.

Additionally, Veren ( VRN ) would enter into a 15-year "take-or-pay"

agreement for capacity at the acquired batteries.

BY THE NUMBERS

The deal is expected to close in the fourth quarter of 2024

and yield C$50 million in annual adjusted EBITDA, of which C$30

million is net to Pembina.

Veren's ( VRN ) use of the proceeds will result in total expected

debt reduction of C$1.3 billion in 2024.

($1 = 1.3565 Canadian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
H.B. Fuller Fiscal Q1 Adjusted Earnings, Revenue Rise
H.B. Fuller Fiscal Q1 Adjusted Earnings, Revenue Rise
Mar 27, 2024
04:25 PM EDT, 03/27/2024 (MT Newswires) -- H.B. Fuller ( FUL ) reported fiscal Q1 adjusted earnings Wednesday of $0.67 per diluted share, up from $0.55 a year earlier. Analysts polled by Capital IQ expected $0.63. Net revenue for the quarter ended March 2 was $810.4 million, up from $809.2 million a year earlier. Analysts surveyed by Capital IQ expected...
Rumble Swings to Q4 Loss, Revenue Increases
Rumble Swings to Q4 Loss, Revenue Increases
Mar 27, 2024
04:28 PM EDT, 03/27/2024 (MT Newswires) -- Rumble (RUM) reported a Q4 loss late Wednesday of $0.14 per diluted share, compared with a break-even a year earlier. One analyst polled by Capital IQ expected a loss of $0.22. Revenue for the quarter ended Dec. 31 was $20.4 million, up from $20 million a year earlier. One analyst surveyed by Capital...
Arcturus Therapeutics Holdings Insider Sold Shares Worth $610,574, According to a Recent SEC Filing
Arcturus Therapeutics Holdings Insider Sold Shares Worth $610,574, According to a Recent SEC Filing
Mar 27, 2024
04:22 PM EDT, 03/27/2024 (MT Newswires) -- Pad Chivukula, Chief Scientific Officer & COO, on March 25, 2024, sold 17,435 shares in Arcturus Therapeutics Holdings ( ARCT ) for $610,574. Following the Form 4 filing with the SEC, Chivukula has control over a total of 473,448 shares of the company, with 473,448 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1768224/000119380524000452/xslF345X03/e663461_4-chivukula.xml ...
Praxis Precision Medicines Plans Public Equity Offering
Praxis Precision Medicines Plans Public Equity Offering
Mar 27, 2024
04:25 PM EDT, 03/27/2024 (MT Newswires) -- Praxis Precision Medicines ( PRAX ) said late Wednesday it plans a public offering of common shares and prefunded warrants to purchase common shares. The company said it also plans to grant the underwriters a 30-day overallotment option to purchase up to an additional 15% shares. The size and pricing of the offering...
Copyright 2023-2026 - www.financetom.com All Rights Reserved